JP Morgan 37th Annual Healthcare conference
Logotype for CVS Health Corporation

CVS Health (CVS) JP Morgan 37th Annual Healthcare conference summary

Event summary combining transcript, slides, and related documents.

Logotype for CVS Health Corporation

JP Morgan 37th Annual Healthcare conference summary

4 Nov, 2026

Operating platform and Aetna transaction

  • Retail includes >9,800 pharmacies, 25% retail prescription share and >1,100 MinuteClinics; Caremark serves 93M members and specialty pharmacy dispenses >$35B annually.

  • Aetna acquisition closed Nov. 28, 2018, at ~$70B equity value and ~$78B total value including assumed debt; funding included $40B senior notes, $5B borrowings and 274.4M shares.

  • Integration continued during district court and Tunney Act review; review was not expected to affect the synergy timeline. Debt was ~$76B excluding leases.

Consumer health strategy and savings

  • Priorities: local access, simpler care navigation and improved health through community, home and digital touchpoints; existing engagement reaches one in three Americans.

  • The system was characterized as complex, episodic and fragmented; a consumer-focused front door would address chronic disease, readmissions, site of care, primary care and complex chronic care.

  • U.S. medical spending was cited at $2.4T, including $2.1T or 86% associated with chronic disease; $500B was estimated as preventable, with $25B-$100B in potential savings.

  • Medical-cost levers include chronic-condition management, fewer readmissions, lower-cost care sites, reduced unnecessary ER visits and expanded primary care.

  • Each 50 bps reduction in medical-cost trend was linked to ~$500M of additional underwriting margin; savings could support competitive investment and membership growth.

Integration milestones and health programs

  • Targeting >$750M in 2020 or year-two synergies from integration, G&A, vendor contracting and medical-cost savings; redundant-function benefits expected from Q1 2019.

  • Purchasing, formulary and plan-design benefits expected through H1 2019, with medical-cost savings toward year-end; 2019-2020 work included corporate rationalization and procurement alignment.

  • High-risk member adherence outreach launched in Q4 2018; cardiovascular services, post-discharge MinuteClinic follow-up and care-management pilots were planned for Q1 2019.

  • Houston concept store planned for February 2019, testing concierge services, chronic-disease screening, in-clinic phlebotomy and prescription support; concept stores also feature nutrition counseling and digital tools.

  • ~$2.6B annual CapEx budget includes store refreshes; up to 20% of store space could shift to health services, with renovations funded within existing capital plans.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more

Latest events from CVS Health